Calcipotriene Topical Solution is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp.
Lupin’s Calcipotriene Topical Solution, 0.005% (Scalp Solution) is the AT rated generic equivalent of Leo Pharmaceutical Products Ltd’s Dovonex Scalp Solution.
Calcipotriene Topical Solution, 0.005% (Scalp Solution) had annual sales of approximately USD 5.9 million in the US, it said.
Lupin manufacturers branded & generic formulations, biotechnology products and APIs, focusing on Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space.
It is the 6th largest generics pharmaceutical company by revenues.
The Company is the 4th largest pharmaceutical player in the US by prescriptions.